Invasix Ltd. is an Israeli based medical device company that develops a broad range of products for minimally invasive cosmetic surgery based on patented proprietary RFAL (Radiofrequency Assisted LipoTightening) technology. Invasix aesthetic devices creates a whole new category of minimally invasive body recontouring and firming procedures offering reliable and effective applications for physicians, and safety and comfort for patients.

Invasix invests highly in R&D to provide our customers with a substantial competitive advantage in treatment solutions. It is with this in mind that the BodyTite platform is equipped with many of the safety and efficacy features that physicians demand most.

Founded in 2008, Invasix has headquarters in Israel with additional offices in the US, Germany, Canada, Hong Kong and Tokyo supporting worldwide distribution.

The BodyTite platform by Invasix has received Health Canada, CE, and ISO clearance.  BodyTite is currently pending FDA clearance.

Invasix also manufactures and distributes non-invasive procedures such as Fractora Skin Resurfacing, Fractora Firm Skin Tightening, Fractora Plus Skin Tightening, and TiteFX Body Contouring solutions.  For more information visit www.invasix.com.

Corporate Headquarters